IDEXX Laboratories (IDXX)
(Delayed Data from NSDQ)
$495.96 USD
-7.64 (-1.52%)
Updated Jun 20, 2024 04:00 PM ET
Pre-Market: $498.00 +2.04 (0.41%) 9:02 AM ET
4-Sell of 5 4
D Value A Growth B Momentum B VGM
Brokerage Reports
IDEXX Laboratories, Inc. [IDXX]
Reports for Purchase
Showing records 321 - 340 ( 425 total )
Company: IDEXX Laboratories, Inc.
Industry: Medical - Instruments
Company: IDEXX Laboratories, Inc.
Industry: Medical - Instruments
Company: IDEXX Laboratories, Inc.
Industry: Medical - Instruments
Company: IDEXX Laboratories, Inc.
Industry: Medical - Instruments
Company: IDEXX Laboratories, Inc.
Industry: Medical - Instruments
Company: IDEXX Laboratories, Inc.
Industry: Medical - Instruments
Q1 results beat handily, vet market healthiest since financial crisis, up target to $80
Provider: Feltl & Company
Analyst: HAYNOR B
Company: IDEXX Laboratories, Inc.
Industry: Medical - Instruments
Feltl Q1 2016 Veterinary Practice Survey 379 veterinarians
Provider: Feltl & Company
Analyst: HAYNOR B
Company: IDEXX Laboratories, Inc.
Industry: Medical - Instruments
Company: IDEXX Laboratories, Inc.
Industry: Medical - Instruments
Company: IDEXX Laboratories, Inc.
Industry: Medical - Instruments
Company: IDEXX Laboratories, Inc.
Industry: Medical - Instruments
Company: IDEXX Laboratories, Inc.
Industry: Medical - Instruments
Company: IDEXX Laboratories, Inc.
Industry: Medical - Instruments
Company: IDEXX Laboratories, Inc.
Industry: Medical - Instruments
Company: IDEXX Laboratories, Inc.
Industry: Medical - Instruments
Company: IDEXX Laboratories, Inc.
Industry: Medical - Instruments
Company: IDEXX Laboratories, Inc.
Industry: Medical - Instruments
Company: IDEXX Laboratories, Inc.
Industry: Medical - Instruments
Beat on bottom line, guidance below expectations, maintain HOLD
Provider: Feltl & Company
Analyst: HAYNOR B
Company: IDEXX Laboratories, Inc.
Industry: Medical - Instruments
Company: IDEXX Laboratories, Inc.
Industry: Medical - Instruments
Feltl Q3 2015 Veterinary Practice Survey - 408 veterinarians
Provider: Feltl & Company
Analyst: HAYNOR B